
Uzbekistan joins global vaccination program
(MENAFN- Trend News Agency) BAKU, Azerbaijan, Aug. 25
By Ilkin Seyfaddini – Trend:
Uzbekistan as an active member of WHO European Regional Office, has joined the Coronavirus vaccination program, Trend reports referring to Coronavirus-Info Telegram Channel.
At a briefing in Geneva, WHO Director-General Tedros Ghebreyesus said that 172 countries have joined the COVAX international mechanism for the development and distribution of vaccine against coronavirus infection.
WHO currently has nine coronavirus vaccines in its portfolio.
Earlier, Uzbek epidemiologist Rustam Ikramov stated that Uzbekistan plans to vaccinate the population against flu and pneumonia in autumn-winter of 2020.
The epidemiologist noted that the government of Uzbekistan develops measures to import vaccines and establish vaccination points at the local level.
As Uzbek media report, country's government is studying the possibility of using COVID-19 vaccines created in Russia and China following Uzbekistan's President Shavkat Mirziyoyev instruction to study the possibility to purchase COVID-19 vaccines abroad.
---
Follow author on Twitter: @seyfaddini

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Thinkmarkets Adds Synthetic Indices To Its Product Offering
- Ethereum Startup Agoralend Opens Fresh Fundraise After Oversubscribed $300,000 Round.
- KOR Closes Series B Funding To Accelerate Global Growth
- Wise Wolves Corporation Launches Unified Brand To Power The Next Era Of Cross-Border Finance
- Lombard And Story Partner To Revolutionize Creator Economy Via Bitcoin-Backed Infrastructure
- FBS AI Assistant Helps Traders Skip Market Noise And Focus On Strategy
Comments
No comment